178372-19-5

Basic information

• Product Name: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol
• Synonyms: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol;2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethan-1-ol
• CAS NO: 178372-19-5
• Molecular Formula: C11H16N2O
• Molecular Weight: 192.26
• Mol File: 178372-19-5.mol

Chemical Properties

• Boiling Point: 353.2 °C at 760 mmHg
• Flash Point: 167.4 °C
• Appearance: /
• Density: 1.094 g/cm³
• Vapor Pressure: 1.34E-05mmHg at 25°C
• Refractive Index: 1.539
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol(178372-19-5)
• EPA Substance Registry System: 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol(178372-19-5)

Safety Data

• Hazardous Substances Data: 178372-19-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol is used as a potential active pharmaceutical ingredient for its possible biological activity, which may be harnessed to develop new drugs or therapeutic agents. 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol's structure, featuring nitrogen-containing rings, could allow it to interact with various biological targets, such as receptors or enzymes, relevant to treating diseases.
Used in Chemical Industry:
In the chemical industry, 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol may serve as a building block or intermediate in the synthesis of more complex molecules with specific applications. Its unique structure could be key in creating novel compounds with tailored properties for use in materials science, catalysis, or as specialty chemicals.
Given the complexity of the compound and the preliminary nature of the information provided, it is essential to conduct comprehensive studies to determine the safety, efficacy, and optimal applications of 2-(3-(pyridin-2-yl)pyrrolidin-3-yl)ethanol in these industries.

InChI:InChI=1/C11H16N2O/c14-8-5-11(4-7-12-9-11)10-3-1-2-6-13-10/h1-3,6,12,14H,4-5,7-9H2

Upstream product

• 178372-18-4 3-(pyridin-2-yl)-5-oxo-pyrrolidin-3-yl-acetic acid ethyl ester 

Relevant articles and documents

SUBSTITUTED 4-(1H-BENZIMIDAZOL-2-YL)[1,4]DIAZEPANES USEFUL FOR THE TREATMENT ALLERGIC DISEASES

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4] diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases

The present invention relates to novel substituted piperidine derivatives of formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted piperidines useful for the treatment of allergic diseases

The present invention relates to novel substituted piperidine derivatives of the formula STR1stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic diseases including: seasonal rhinitis, allergic rhinitis, and sinusitis.

Novel substituted 4-(1H-benzimidazol-2-yl) [1,4]diazepanes useful for the treatment of allergic diseases

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula (1): and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.